Study Details

General Information

GSK53 Harmony

Harmony-3, “A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group, Multicenter Study to Determine the Efficacy and Safety of (study drug) When used in Combinaton Wiith Metformin Compared with Metfomin Plus Stagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus”

ProtocolGLP112753
IdentifierGLP112753
UID32f78f41-9554-45b0-892d-be4510f0c1a1
StatusDone - Archived
Phase3
CategoryDiabetes Type 2 / Adult
Launch Year2009
NCT Number-
Created2010-05-21 16:00
Last Updated2010-05-21 16:00

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First Visit2009-07-31No
Site Initiation Mtg.2009-02-04No
PI Meeting Start2008-12-10No
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2013-05-15No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalUnger, JeffreyJUngerNo
Recruiter-No
CoordinatorPereira, CynthiaCPereiraNo
RegulatoryAguirre, SandraSAguirreNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorGlaxoSmithKline
DivisionGlaxoSmithKline
TeamGlaxoSmithKline
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB RefIRB ID NO. 24253/293
CROPPD Investigator Services, LLC
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?